ABCC1 (P33527) variants and mutations
ABCC1 (also known as P33527) is a human protein-coding gene encoding a multidrug resistance-associated protein 1 protein. Its annotated function is mediates export of organic anions and drugs from the cytoplasm. It is annotated at the cell membrane. This analysis covers 1,867 ABCC1 variants and mutations. Of these, 76% have computational variant effect predictions. Disease context includes Abnormality of the skeletal system, hearing loss, autosomal dominant 77, and hereditary breast carcinoma. Example ABCC1 variants include A2T, A2P, and A2S.
Variant analysis overview
- Gene: ABCC1
- Protein: P33527
- UniProt accession: P33527
- Organism: Homo sapiens
- Variants analyzed: 1867
- Variant scope: all variants
- Completed: 2026-08-28
Variant and mutation evidence
- Variant composition: 1,701 unspecified-consequence records; 92 missense variants; 53 synonymous variants; 12 frameshift variants; 5 stop-gained variants; 2 in-frame deletions; 1 splice-region variants; 1 substitution
- Prediction scores: 1,417 variants have prediction scores (76% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Abnormality of the skeletal system, hearing loss, autosomal dominant 77, hereditary breast carcinoma, Hereditary breast cancer, autosomal dominant nonsyndromic hearing loss, alcohol drinking, ischemic stroke, diaphragm disorder, Abnormality of prenatal development or birth, nonsyndromic deafness, neurodegenerative disease, neoplasm.
Protein structure and variant hotspots
- Protein features: 17 transmembrane segments; 4 domains; 4 binding sites; 9 post-translational modification sites.
- Structural context: 1,279 variants have structural context.
- PTM context: 12 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ABCC1 variants
Examples include A2T, A2P, A2S, A2G, A2V, A2E, A2A, L3I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2T (p.Ala2Thr), gnomAD 16-15949755-G-A, REVEL 0.07, CADD 22.70
- A2P (p.Ala2Pro), gnomAD 16-15949755-G-C, REVEL 0.16, CADD 22.80
- A2S (p.Ala2Ser), gnomAD 16-15949755-G-T, REVEL 0.06, CADD 21.80
- A2G (p.Ala2Gly), gnomAD 16-15949756-C-G, REVEL 0.06, CADD 19.10
- A2V (p.Ala2Val), gnomAD 16-15949756-C-T, REVEL 0.05, CADD 23.10
- A2E (p.Ala2Glu), gnomAD 16-15949756-C-A, REVEL 0.10, CADD 21.00
- A2A (p.Ala2Ala), gnomAD 16-15949757-G-T, CADD 15.10
- L3I (p.Leu3Ile), gnomAD 16-15949758-C-A, REVEL 0.06, CADD 21.10
- L3F (p.Leu3Phe), gnomAD 16-15949758-C-T, REVEL 0.06, CADD 22.10
- L3H (p.Leu3His), gnomAD 16-15949759-T-A, REVEL 0.21, CADD 25.80
- L3P (p.Leu3Pro), gnomAD 16-15949759-T-C, REVEL 0.23, CADD 26.40
- L3L (p.Leu3Leu), gnomAD 16-15949760-C-T, CADD 14.30
- R4L (p.Arg4Leu), TOPMed rs2045820839, gnomAD rs2045820839, REVEL 0.10, CADD 23.90
- R4P (p.Arg4Pro), TOPMed rs2045820839, gnomAD rs2045820839, REVEL 0.11, CADD 23.00
- R4W (p.Arg4Trp), gnomAD rs1389170089, REVEL 0.13, CADD 24.40
- R4G (p.Arg4Gly), gnomAD 16-15949759-TC-T, CADD 25.70
- R4R (p.Arg4Arg), gnomAD 16-15949761-C-A, CADD 15.00
- R4Q (p.Arg4Gln), gnomAD 16-15949762-G-A, REVEL 0.07, CADD 22.90
- G5A (p.Gly5Ala), gnomAD 16-15949761-CG-C, CADD 26.60
- G5S (p.Gly5Ser), gnomAD 16-15949764-G-A, REVEL 0.04, CADD 17.40
- G5C (p.Gly5Cys), gnomAD 16-15949764-G-T, REVEL 0.08, CADD 23.40
- G5R (p.Gly5Arg), gnomAD 16-15949764-G-C, REVEL 0.03, CADD 19.00
- G5D (p.Gly5Asp), gnomAD 16-15949765-G-A, REVEL 0.04, CADD 21.30
- G5V (p.Gly5Val), gnomAD 16-15949765-G-T, REVEL 0.03, CADD 22.40
- G5G (p.Gly5Gly), gnomAD 16-15949766-C-G, CADD 15.30
- F6V (p.Phe6Val), TOPMed rs1306445236
- F6L (p.Phe6Leu), gnomAD 16-15949767-T-C, REVEL 0.12, CADD 22.70
- F6S (p.Phe6Ser), gnomAD 16-15949768-T-C, REVEL 0.28, CADD 24.50
- F6F (p.Phe6Phe), gnomAD 16-15949769-C-T, CADD 15.40
- C7R (p.Cys7Arg), gnomAD 16-15949770-T-C, REVEL 0.38, CADD 24.40
- C7Y (p.Cys7Tyr), gnomAD 16-15949771-G-A, REVEL 0.36, CADD 24.20
- C7F (p.Cys7Phe), gnomAD 16-15949771-G-T, REVEL 0.34, CADD 24.20
- C7W (p.Cys7Trp), gnomAD 16-15949772-C-G, REVEL 0.40, CADD 26.30
- C7C (p.Cys7Cys), rs1273013410, gnomAD 16-15949772-C-T, CADD 15.90
- C7* (p.Cys7Ter), gnomAD 16-15949772-C-A, CADD 37.00
- S8G (p.Ser8Gly), TOPMed rs1220102099, REVEL 0.03, CADD 16.20
- S8N (p.Ser8Asn), TOPMed rs2045821155, REVEL 0.05, CADD 18.90
- S8I (p.Ser8Ile), gnomAD 16-15949774-G-T, REVEL 0.06, CADD 22.70
- S8S (p.Ser8Ser), gnomAD 16-15949775-C-T, CADD 11.90
- S8R (p.Ser8Arg), gnomAD 16-15949775-C-A, REVEL 0.05, CADD 12.80
- A9V (p.Ala9Val), Ensembl rs2045821234, REVEL 0.03, CADD 17.20
- A9T (p.Ala9Thr), gnomAD 16-15949776-G-A, REVEL 0.03, CADD 17.50
- A9P (p.Ala9Pro), gnomAD 16-15949776-G-C, REVEL 0.12, CADD 19.70
- A9S (p.Ala9Ser), gnomAD 16-15949776-G-T, REVEL 0.07, CADD 15.30
- A9D (p.Ala9Asp), gnomAD 16-15949777-C-A, REVEL 0.07, CADD 18.80
- A9A (p.Ala9Ala), gnomAD 16-15949778-C-T, CADD 13.30
- D10Y (p.Asp10Tyr), gnomAD rs1228887228, REVEL 0.15, CADD 23.70
- D10N (p.Asp10Asn), gnomAD 16-15949779-G-A, REVEL 0.03, CADD 22.50
- D10H (p.Asp10His), gnomAD 16-15949779-G-C, REVEL 0.08, CADD 25.30
- D10G (p.Asp10Gly), gnomAD 16-15949780-A-G, REVEL 0.08, CADD 22.90
- D10V (p.Asp10Val), gnomAD 16-15949780-A-T, REVEL 0.14, CADD 23.00
- D10D (p.Asp10Asp), gnomAD 16-15949781-T-C, CADD 13.90
- G11V (p.Gly11Val), TOPMed rs953725451, gnomAD rs953725451, REVEL 0.16, CADD 21.60
- G11S (p.Gly11Ser), gnomAD 16-15949782-G-A, REVEL 0.12, CADD 22.60
- G11D (p.Gly11Asp), gnomAD 16-15949783-G-A, REVEL 0.19, CADD 22.40
- G11G (p.Gly11Gly), rs562494702, gnomAD 16-15949784-C-T, CADD 13.70
- S12P (p.Ser12Pro), gnomAD rs2045821621, REVEL 0.12, CADD 22.40
- S12T (p.Ser12Thr), gnomAD 16-15949785-T-A, REVEL 0.03, CADD 18.80
- S12C (p.Ser12Cys), gnomAD 16-15949786-C-G, REVEL 0.12, CADD 22.30
- S12Y (p.Ser12Tyr), gnomAD 16-15949786-C-A, REVEL 0.13, CADD 18.70
- S12F (p.Ser12Phe), gnomAD 16-15949786-C-T, REVEL 0.10, CADD 21.30
- S12S (p.Ser12Ser), rs1341088890, gnomAD 16-15949787-C-T, CADD 13.50
- D13H (p.Asp13His), TOPMed rs1369432476, REVEL 0.16, CADD 22.90
- D13N (p.Asp13Asn), TOPMed rs1369432476, REVEL 0.15, CADD 22.90
- D13Y (p.Asp13Tyr), gnomAD 16-15949788-G-T, REVEL 0.31, CADD 24.00
- D13G (p.Asp13Gly), gnomAD 16-15949789-A-G, REVEL 0.14, CADD 22.70
- D13D (p.Asp13Asp), gnomAD 16-15949790-C-T, CADD 13.10
- D13E (p.Asp13Glu), gnomAD 16-15949790-C-G, REVEL 0.04, CADD 17.30
- P14L (p.Pro14Leu), TOPMed rs2045821860, REVEL 0.02, CADD 23.10
- P14R (p.Pro14Arg), TOPMed rs2045821860, REVEL 0.03, CADD 21.00
- P14T (p.Pro14Thr), gnomAD 16-15949791-C-A, REVEL 0.01, CADD 18.80
- P14S (p.Pro14Ser), gnomAD 16-15949791-C-T, REVEL 0.03, CADD 19.90
- P14Q (p.Pro14Gln), gnomAD 16-15949792-C-A, REVEL 0.07, CADD 22.90
- P14P (p.Pro14Pro), rs1296417878, gnomAD 16-15949793-G-T, CADD 9.39
- L15F (p.Leu15Phe), TOPMed rs909494728, REVEL 0.07, CADD 12.80
- L15H (p.Leu15His), TOPMed rs2045822102, gnomAD rs2045822102, REVEL 0.20, CADD 23.70
- L15P (p.Leu15Pro), TOPMed rs2045822102, gnomAD rs2045822102, REVEL 0.34, CADD 23.80, Uncertain significance, not specified
- L15I (p.Leu15Ile), gnomAD 16-15949794-C-A, REVEL 0.05, CADD 19.60
- L15V (p.Leu15Val), gnomAD 16-15949794-C-G, REVEL 0.07, CADD 19.20
- L15L (p.Leu15Leu), gnomAD 16-15949796-C-G, CADD 13.70
- W16C (p.Trp16Cys), Ensembl rs1597044398, REVEL 0.25, CADD 33.00
- W16G (p.Trp16Gly), gnomAD 16-15949793-GCT-G, CADD 25.70
- W16S (p.Trp16Ser), gnomAD 16-15949793-G-GCT, CADD 23.40
- W16R (p.Trp16Arg), gnomAD 16-15949797-T-C, REVEL 0.20, CADD 24.40
- W16* (p.Trp16Ter), gnomAD 16-15949798-G-A, CADD 38.00
- D17E (p.Asp17Glu), Ensembl rs2151724268
- D17V (p.Asp17Val), rs769528847, ClinGen CA7923391, ClinVar RCV004213637, ExAC rs769528847, REVEL 0.71, CADD 26.50, Uncertain significance, not specified
- D17Y (p.Asp17Tyr), rs761719926, ClinGen CA7923390, NCI-TCGA Cosmic COSV1005, ClinVar RCV004213636, REVEL 0.61, CADD 33.00, Uncertain significance, not specified
- D17G (p.Asp17Gly), gnomAD 16-16007817-A-G, REVEL 0.54, CADD 24.70
- W18C (p.Trp18Cys), ExAC rs773051838, TOPMed rs773051838, gnomAD rs773051838, REVEL 0.34, CADD 24.70
- W18R (p.Trp18Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V20A (p.Val20Ala), gnomAD 16-16007826-T-C, REVEL 0.08, CADD 13.60
- V20V (p.Val20Val), gnomAD 16-16007827-C-T, CADD 5.80
- T21M (p.Thr21Met), rs762542019, ExAC rs762542019, gnomAD rs762542019, NCI-TCGA Cosmic COSV1005, REVEL 0.29, CADD 24.70, Variant assessed as somatic; moderate impact.
- T21T (p.Thr21Thr), rs765984154, gnomAD 16-16007830-G-A, CADD 3.32
- N23I (p.Asn23Ile), ExAC rs760030871, gnomAD rs760030871, REVEL 0.10, CADD 22.30
- N23K (p.Asn23Lys), gnomAD rs1297776332, REVEL 0.03, CADD 16.20
- N23T (p.Asn23Thr), ExAC rs760030871, gnomAD rs760030871, REVEL 0.09, CADD 21.70
- N23D (p.Asn23Asp), gnomAD 16-16007834-A-G, REVEL 0.04, CADD 12.00
- T24T (p.Thr24Thr), rs1228665820, gnomAD 16-16007839-C-T, CADD 11.60
- N26K (p.Asn26Lys), gnomAD rs1314663568, REVEL 0.20, CADD 19.20
- N26T (p.Asn26Thr), Ensembl rs2047604460
- N26Y (p.Asn26Tyr), TOPMed rs1362428434
- P27L (p.Pro27Leu), gnomAD rs909053714, REVEL 0.46, CADD 26.30
- P27T (p.Pro27Thr), TOPMed rs2047604747
- P27P (p.Pro27Pro), rs375663357, gnomAD 16-16007848-C-T, CADD 4.83
- D28N (p.Asp28Asn), TOPMed rs1036468233, gnomAD rs1036468233, REVEL 0.38, CADD 28.90, Uncertain significance, not specified
- F29L (p.Phe29Leu), gnomAD 16-16007848-C-CGA, CADD 32.00
- F29S (p.Phe29Ser), gnomAD 16-16007850-AC-A, CADD 24.60
- F29F (p.Phe29Phe), rs753066610, gnomAD 16-16007854-C-T, CADD 12.30
- T30T (p.Thr30Thr), rs1440249186, gnomAD 16-16007857-C-T, CADD 12.70
- K31M (p.Lys31Met), rs2508882761, ClinGen CA394877825, ClinVar RCV004424552, REVEL 0.30, CADD 25.90, Uncertain significance, not specified
- K31N (p.Lys31Asn), ExAC rs756513465, gnomAD rs756513465, REVEL 0.16, CADD 22.80
- K31K (p.Lys31Lys), rs756513465, gnomAD 16-16007860-G-A, CADD 10.90
- F33L (p.Phe33Leu), ExAC rs754116395, gnomAD rs754116395, REVEL 0.48, CADD 25.10
- F33I (p.Phe33Ile), gnomAD 16-16007864-T-A, REVEL 0.71, CADD 28.40
- Q34R (p.Gln34Arg), gnomAD 16-16007868-A-G, REVEL 0.40, CADD 26.90
- Q34Q (p.Gln34Gln), gnomAD 16-16007869-G-A, CADD 10.20
- N35K (p.Asn35Lys), ExAC rs757323996, TOPMed rs757323996, gnomAD rs757323996, REVEL 0.18, CADD 22.80
- N35T (p.Asn35Thr), rs2047606443, gnomAD 16-16007869-GA-G, CADD 31.00
- N35I (p.Asn35Ile), gnomAD 16-16007871-A-T, REVEL 0.47, CADD 27.20
- T36K (p.Thr36Lys), TOPMed rs1182782351, gnomAD rs1182782351, REVEL 0.58, CADD 25.70
- T36M (p.Thr36Met), TOPMed rs1182782351, gnomAD rs1182782351, REVEL 0.52, CADD 25.80
- T36T (p.Thr36Thr), rs778984777, gnomAD 16-16007875-G-C, CADD 2.52
- V37I (p.Val37Ile), gnomAD rs1427138675, REVEL 0.02, CADD 8.34
- V37V (p.Val37Val), rs2047607508, gnomAD 16-16007878-C-T, CADD 8.91
- L38L (p.Leu38Leu), rs745945401, gnomAD 16-16007881-C-T, CADD 4.34
- V39G (p.Val39Gly), Ensembl rs2047608117
- V39L (p.Val39Leu), 1000Genomes rs538744747, ExAC rs538744747, TOPMed rs538744747, gnomAD rs538744747, REVEL 0.11, CADD 16.70
- V39M (p.Val39Met), 1000Genomes rs538744747, ExAC rs538744747, TOPMed rs538744747, gnomAD rs538744747, REVEL 0.14, CADD 17.60
- V41A (p.Val41Ala), gnomAD rs2047608424, REVEL 0.05, CADD 20.90
- V41L (p.Val41Leu), gnomAD rs769264477, REVEL 0.03, CADD 20.10
- V41V (p.Val41Val), gnomAD 16-16007890-G-T, CADD 10.30
- C43R (p.Cys43Arg), TOPMed rs2047608663
- C43S (p.Cys43Ser), rs41395947, 1000Genomes rs41395947, ExAC rs41395947, TOPMed rs41395947, REVEL 0.43, CADD 25.00
- C43Y (p.Cys43Tyr), gnomAD 16-16007895-G-A, REVEL 0.61, CADD 28.30
- C43C (p.Cys43Cys), rs1404866722, gnomAD 16-16007896-T-C, CADD 6.97
- F44L (p.Phe44Leu), TOPMed rs1377886355, REVEL 0.01, CADD 12.30
- Y45L (p.Tyr45Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Y45F (p.Tyr45Phe), gnomAD 16-16007901-A-T, REVEL 0.17, CADD 20.60
- Y45* (p.Tyr45Ter), gnomAD 16-16007901-ACCTC, CADD 33.00
- L46L (p.Leu46Leu), gnomAD 16-16007905-C-T, CADD 10.50
- W47* (p.Trp47Ter), Ensembl rs1597107671
- W47C (p.Trp47Cys), ExAC rs747917739, gnomAD rs747917739, REVEL 0.61, CADD 28.70
- A48G (p.Ala48Gly), Ensembl rs2047609498
- A48T (p.Ala48Thr), ExAC rs769771635, TOPMed rs769771635, gnomAD rs769771635, REVEL 0.04, CADD 13.60
- A48S (p.Ala48Ser), gnomAD 16-16007909-G-T, REVEL 0.03, CADD 11.80
- C49R (p.Cys49Arg), gnomAD rs1213779535, REVEL 0.23, CADD 23.60
- C49S (p.Cys49Ser), gnomAD rs2047609874, REVEL 0.15, CADD 21.10
- C49V (p.Cys49Val), rs764056337, gnomAD 16-16007911-CT-C, CADD 26.00
- C49C (p.Cys49Cys), gnomAD 16-16007914-T-C, CADD 9.44
- P51L (p.Pro51Leu), ExAC rs772997137, gnomAD rs772997137, REVEL 0.26, CADD 23.40
- P51A (p.Pro51Ala), gnomAD 16-16007918-C-G, REVEL 0.41, CADD 23.00
- P51P (p.Pro51Pro), gnomAD 16-16007920-C-A, CADD 9.24
- F52S (p.Phe52Ser), gnomAD 16-16007916-TC-T, CADD 25.00
- F52L (p.Phe52Leu), gnomAD 16-16007921-T-C, REVEL 0.05, CADD 14.30
- Y53C (p.Tyr53Cys), rs762631300, ExAC rs762631300, gnomAD rs762631300, ClinGen CA7923411, REVEL 0.56, CADD 29.10, Uncertain significance, not specified
- Y53D (p.Tyr53Asp), gnomAD rs1319994715, REVEL 0.44, CADD 25.20
- Y53S (p.Tyr53Ser), gnomAD 16-16007925-A-C, REVEL 0.47, CADD 28.40
- Y53Y (p.Tyr53Tyr), gnomAD 16-16007926-C-T, CADD 9.05
- p.Phe54 Tyr56del, gnomAD 16-16007921-TTCTA, CADD 19.40
- F54F (p.Phe54Phe), rs2047610365, gnomAD 16-16007929-C-T, CADD 12.10
- F54L (p.Phe54Leu), gnomAD 16-16007929-C-A, REVEL 0.06, CADD 16.70
- L55R (p.Leu55Arg), gnomAD rs1261393739
- L55F (p.Leu55Phe), gnomAD 16-16007930-C-T, REVEL 0.04, CADD 15.20
- L55L (p.Leu55Leu), rs1339980456, gnomAD 16-16007932-C-G, CADD 7.97
- Y56C (p.Tyr56Cys), ExAC rs565023011, TOPMed rs565023011, gnomAD rs565023011, REVEL 0.21, CADD 23.70
- Y56H (p.Tyr56His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y56S (p.Tyr56Ser), ExAC rs565023011, TOPMed rs565023011, gnomAD rs565023011, REVEL 0.18, CADD 22.70
- L57P (p.Leu57Pro), rs2047610961, TOPMed rs2047610961, ClinGen CA394878379, ClinVar RCV004424397, AlphaMissense 0.93, MetaLR 0.41, Uncertain significance, not specified
- L57V (p.Leu57Val), ESP rs199949505, ExAC rs199949505, TOPMed rs199949505, gnomAD rs199949505, REVEL 0.22, CADD 24.60
- L57L (p.Leu57Leu), rs759000895, gnomAD 16-16007938-C-T, CADD 8.42
- S58Y (p.Ser58Tyr), TOPMed rs1359256046, gnomAD rs1359256046, REVEL 0.03, CADD 15.70
- S58C (p.Ser58Cys), gnomAD 16-16007940-C-G, REVEL 0.03, CADD 19.40
- R59* (p.Arg59Ter), rs768037858, NCI-TCGA Cosmic COSV6069, ExAC rs768037858, gnomAD rs768037858, CADD 36.00, Variant assessed as somatic; high impact.
- R59Q (p.Arg59Gln), TOPMed rs370745195, gnomAD rs370745195, REVEL 0.04, CADD 9.21
- R59G (p.Arg59Gly), gnomAD 16-16007942-C-G, REVEL 0.10, CADD 19.30
- R59R (p.Arg59Arg), rs768037858, gnomAD 16-16007942-C-A, CADD 11.00
- R59P (p.Arg59Pro), gnomAD 16-16007943-G-C, REVEL 0.17, CADD 11.10
- H60P (p.His60Pro), TOPMed rs903368377, gnomAD rs903368377
Public ABCC1 analysis runs
- ABCC1 analysis run — ABCC1 (1,867 variants) — completed 2026-08-28